Estabrook Capital Management Abb Vie Inc. Transaction History

Estabrook Capital Management

$671 Billion
Q3 2024

A detailed history of Estabrook Capital Management transactions in Abb Vie Inc. stock. As of the latest transaction made, Estabrook Capital Management holds 15,273 shares of ABBV stock, worth $2.75 Million. This represents 0.45% of its overall portfolio holdings.

Number of Shares

15,273

Previous 15,523 1.61%

Holding current value

$2.75 Million

Previous $2.66 Billion 13.28%

% of portfolio

0.45%

Previous 0.41%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$163.84 - $199.33 $40,960 - $49,832	-250 Reduced 1.61%	15,273 $3.02 Billion
Q4 2023 Feb 13, 2024	SELL	$137.6 - $154.97 $64,259 - $72,370	-467 Reduced 2.92%	15,523 $2.41 Billion
Q3 2023 Nov 13, 2023	SELL	$133.59 - $154.65 $111,146 - $128,668	-832 Reduced 4.95%	15,990 $2.38 Billion
Q4 2022 Feb 13, 2023	SELL	$138.31 - $165.87 $6,915 - $8,293	-50 Reduced 0.3%	16,822 $2.72 Billion
Q3 2022 Nov 14, 2022	SELL	$134.21 - $153.93 $45,631 - $52,336	-340 Reduced 1.98%	16,872 $2.26 Billion
Q2 2022 Aug 15, 2022	BUY	$137.62 - $174.96 $69,085 - $87,829	502 Added 3.0%	17,212 $2.64 Million
Q1 2022 May 13, 2022	SELL	$131.98 - $163.75 $247,330 - $306,867	-1,874 Reduced 10.08%	16,710 $2.71 Million
Q4 2021 Feb 11, 2022	SELL	$107.43 - $135.93 $1,181 - $1,495	-11 Reduced 0.06%	18,584 $2.52 Million
Q3 2021 Nov 15, 2021	SELL	$106.4 - $120.78 $183,965 - $208,828	-1,729 Reduced 8.51%	18,595 $2.01 Million
Q2 2021 Aug 13, 2021	SELL	$105.21 - $117.21 $410,634 - $457,470	-3,903 Reduced 16.11%	20,324 $2.29 Million
Q1 2021 May 14, 2021	BUY	$102.3 - $112.62 $306 - $337	3 Added 0.01%	24,227 $2.62 Million
Q4 2020 Feb 12, 2021	BUY	$80.49 - $108.67 $383,615 - $517,921	4,766 Added 24.49%	24,224 $2.6 Million
Q3 2020 Nov 13, 2020	BUY	$85.91 - $100.83 $941,401 - $1.1 Million	10,958 Added 128.92%	19,458 $1.7 Million
Q2 2020 Aug 13, 2020	BUY	$73.37 - $98.18 $440 - $589	6 Added 0.07%	8,500 $834,000
Q1 2020 May 14, 2020	BUY	$64.5 - $97.79 $709 - $1,075	11 Added 0.13%	8,494 $647,000
Q4 2019 Feb 13, 2020	SELL	$72.13 - $90.25 $14,281 - $17,869	-198 Reduced 2.28%	8,483 $751,000
Q3 2019 Nov 13, 2019	BUY	$62.98 - $75.72 $1,511 - $1,817	24 Added 0.28%	8,681 $657,000
Q2 2019 Aug 13, 2019	SELL	$65.7 - $83.98 $32,850 - $41,990	-500 Reduced 5.46%	8,657 $0
Q1 2019 May 13, 2019	SELL	$77.14 - $90.79 $301,385 - $354,716	-3,907 Reduced 29.91%	9,157 $0
Q4 2018 Feb 14, 2019	SELL	$77.85 - $96.01 $272,085 - $335,554	-3,495 Reduced 21.11%	13,064 $1.2 Million
Q3 2018 Nov 13, 2018	SELL	$88.91 - $98.84 $217,829 - $242,158	-2,450 Reduced 12.89%	16,559 $0
Q2 2018 Aug 14, 2018	SELL	$89.78 - $106.23 $107,736 - $127,476	-1,200 Reduced 5.94%	19,009 $0
Q1 2018 May 14, 2018	SELL	$92.01 - $123.21 $18,402 - $24,642	-200 Reduced 0.98%	20,209 $0
Q4 2017 Feb 12, 2018	SELL	$89.56 - $98.21 $8,329 - $9,133	-93 Reduced 0.45%	20,409 $0
Q3 2017 Nov 09, 2017	BUY	$69.85 - $89.22 $1.43 Million - $1.83 Million	20,502	20,502 $0

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Estabrook Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Estabrook Capital Management with notifications on news.

Account

Estabrook Capital Management Abb Vie Inc. Transaction History